Which hip option fits the soreness and the exam?

What is PRP?

PRP is short for platelet-rich plasma, which clinic staff make by spinning a tube of your blood. The spinning gathers platelets, the small blood pieces that help it clot. Staff then put the prepared fluid into the chosen hip area with a needle. Concentrated PRP follows those steps but may gather a higher share of platelets.

Ask how the clinic's regular PRP differs from its concentrated PRP. The answer should name what changes in the prepared blood and why it matters to you. Neither choice requires taking marrow from the pelvis or fat from under the skin. Clinic staff can explain where the prepared fluid will go.

What are regenerative treatments?

Regenerative treatments use a patient's blood or tissue as the prepared material. Biologic therapies is another name for this blood- or tissue-based care. Some choices begin with marrow drawn from the back of the pelvis. Others begin by removing a small amount of fat from under the skin.

Those added needle steps may bring more soreness, care needs, and recovery time. Some clinics call these choices natural pain treatments because the material comes from the body. That name doesn't show whether a choice fits the sore hip. The exam must first identify the area that needs care.

What should I ask before choosing?

Ask what the clinic will collect and how it will be prepared. Find out who performs each needle step and where the material will go. Request the full price, including later checks and any added care. Ask when you may resume walking, driving, and usual errands.

Name one task the hip now keeps you from doing. Tell the clinic whether that task is a park walk, stairs, or sleep. Ask what result is realistic and when it would be checked. Find out how the clinic responds when soreness stays the same.

Could this be one of my hip replacement alternatives?

Hip replacement alternatives may be discussed before an operation is scheduled. They can't promise that worn bone or cartilage will change. Severe soreness at rest or a major loss of motion may make surgery more likely. Keep walking within an amount the hip can handle until the exam.

Compare each choice by price, needle steps, recovery days, and likely relief. Tell the clinic if a surgeon is already planning a hip replacement. Both offices need to know about recent care and speak about timing. At QC Kinetix in Chandler, you can discuss non-surgical regenerative treatments, or care prepared from blood or tissue.

Sources

1. A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.. Nature medicine, 2023. DOI: 10.1038/s41591-023-02632-w.

2. A randomized trial of 90 patients with KL grade 1-3 knee OA found bone marrow aspirate concentrate - the product most often sold as a 'stem cell injection' - was EQUIVALENT to, not better than, PRP through 24 months, with no statistically significant IKDC or WOMAC difference at any time point. Both arms improved from baseline and plateaued at 3 months.

   Anz AW, et al. — Bone Marrow Aspirate Concentrate Is Equivalent to Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis at 2 Years: A Prospective Randomized Trial.. The American journal of sports medicine, 2022. DOI: 10.1177/03635465211072554.

3. A Level-1 systematic review of 8 randomized trials (937 patients) of bone marrow aspirate concentrate for knee OA found BMAC improved clinical scores versus baseline from one month, and beat hyaluronic acid on pain at 6 and 12 months with statistical significance - but those differences DID NOT EXCEED the minimal clinically important difference, and against other injections no significant difference appeared at all. Statistically detectable is not the same as noticeable.

   Han JH, et al. — Bone Marrow Aspirate Concentrate Injections for the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials.. Orthopaedic journal of sports medicine, 2024. DOI: 10.1177/23259671241296555.

4. A meta-analysis of 9 Level-1 trials (671 patients) of adipose stromal vascular fraction and adipose-derived MSC injections for knee OA found SVF superior to saline or hyaluronic acid on pain and function at 3, 6 and 12 months - but INFERIOR to corticosteroid at 3 months, no different at 6, and only comparable or slightly superior at 12. Adipose-derived MSCs beat saline and conservative care but showed no significant difference versus HA. No serious adverse events were attributed to the injections themselves, though complications associated with the LIPOSUCTION step were observed.

   Han JH, et al. — Intra-articular Stromal Vascular Fraction and Mesenchymal Stem Cell Injections Show Variable Efficacy and Higher Potential Complications Compared to Corticosteroid and Hyaluronic Acid in Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials.. Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association, 2025. DOI: 10.1016/j.arthro.2025.01.050.

5. The strongest recent POSITIVE signal: a meta-analysis of 10 RCTs (818 patients, KL I-III) found intra-articular MSC injection beat hyaluronic acid at 12 months on WOMAC total (MD -10.22), VAS (MD -1.31) and on the MRI Whole-Organ Magnetic Resonance Imaging Score (MD -26.01), all reaching the minimal clinically important difference, with no significant difference in adverse events. Recorded here at full weight: this result and the negative RESTORE and Mautner trials are both in the literature, and an honest page reports both.

   Jin WS, et al. — Mesenchymal Stem Cells Injection Is More Effective Than Hyaluronic Acid Injection in the Treatment of Knee Osteoarthritis With Similar Safety: A Systematic Review and Meta-analysis.. Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association, 2025. DOI: 10.1016/j.arthro.2024.07.027.

6. A Mayo Clinic single-blind placebo-controlled trial used each patient as their own control: 25 patients with BILATERAL knee OA received bone marrow aspirate concentrate in one knee and saline in the other. Pain fell significantly in BOTH knees at 1 week, 3 months and 6 months - and the relief, described by the authors as dramatic, did NOT differ significantly between the BMAC knee and the saline knee. No serious adverse events occurred.

   Shapiro SA, et al. — A Prospective, Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis.. The American journal of sports medicine, 2017. DOI: 10.1177/0363546516662455.

7. A Bayesian network meta-analysis of 11 randomized trials (1353 patients) in hip osteoarthritis found that at 2-4 months and 6 months NO injectable - corticosteroid, hyaluronic acid or platelet-rich plasma - significantly outperformed a saline placebo injection for pain or function. Pooled change from baseline exceeded the minimal clinically important difference in every arm including placebo.

   Gazendam A, et al. — Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials.. British Journal of Sports Medicine, 2021. DOI: 10.1136/bjsports-2020-102179.